(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 96%

cas: 4338-48-1 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

(2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 96% (CAS 4338-48-1) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 100mg, 250mg, 1g, 5g. Oferty producentów: Combi-blocks.

• 2D
• 3D

(2R,3R,4S,5R)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol (CAS 4338-48-1) to związek chemiczny o wzorze sumarycznym C12H17N5O5 i masie molowej 311.29 g/mol. Nazwa systematyczna IUPAC: (2R,3R,4S,5R)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol. InChIKey: BBOCDRLDMQHWJP-WOUKDFQISA-N.

Dane identyfikacyjne

Wzór sumaryczny	C12H17N5O5
Masa molowa	311.29 g/mol
Nazwa IUPAC	(2R,3R,4S,5R)-2-[6-(2-hydroxyethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
InChIKey	BBOCDRLDMQHWJP-WOUKDFQISA-N
SMILES	C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NCCO

Dane obliczone przez PubChem (NCBI)

Synonimy: n6-(2-hydroxyethyl)adenosine, N-(2-Hydroxyethyl)adenosine, Adenosine, N-(2-hydroxyethyl)-, 6-(2-Hydroxyethyl)amino-9-beta-D-ribofuranosylpurine, n-(2-hydroxyethyl)-9-pentofuranosyl-9h-purin-6-amine, N-hydroxyethyl adenosine, orb1741474, orb2900190, purine, 6-(2-hydroxyethylamino)-9-beta-D-ribofuranosyl-, (2R,3R,4S,5R)-2-(6-((2-Hydroxyethyl)amino)-9H-purin-9-yl)-5-(hydroxy

Izomery (ten sam wzór sumaryczny)

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(dimethylamino)-1H-purin-6-one C₁₂H₁₇N₅O₅

(2R,3S,5R)-5-[2-amino-6-(2-hydroxyethoxy)purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol C₁₂H₁₇N₅O₅

[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] propanoate C₁₂H₁₇N₅O₅

(2R,3R,4S,5R)-2-(6-amino-2-ethoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol C₁₂H₁₇N₅O₅

2-amino-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1-methylpurin-6-one C₁₂H₁₇N₅O₅

(2R,3R,4S,5R)-2-(2-amino-6-ethoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol C₁₂H₁₇N₅O₅

2-amino-5-(aminomethyl)-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one C₁₂H₁₇N₅O₅

9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-2-(methylamino)-1H-purin-6-one C₁₂H₁₇N₅O₅

(2R,3R,4R,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)-3-methyloxolane-3,4-diol C₁₂H₁₇N₅O₅

2-amino-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-8-methyl-1H-purin-6-one C₁₂H₁₇N₅O₅

2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-1-methylpurin-6-one C₁₂H₁₇N₅O₅

9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(ethylamino)-1H-purin-6-one C₁₂H₁₇N₅O₅